Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

21 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Butoconazole Articles

KV's 4th-qtr 2006 net income increases 16%

19 February 2007

KV and Richter Gedeon expand license deal

12 December 2005

KV Pharma licenses two women's products for Mexico

17 January 2005

Arrow to market KV's Gynazole in Australia and NZ

12 April 2004

Hugang to market KV's Gynazole-1 in China

1 March 2004

KV Pharma to sell thrush product in Brazil

15 July 2002

KV's Gynazole-1 targets $175M US market

15 June 2000

Roche Purchases KV Stock

7 April 1997

FDA Clears First One-Dose OTC Thrush Therapy

24 February 1997

Roche's 1996 Sales Ahead Of Expectations

27 January 1997

FDA Year-End Approvals Round-Up

8 January 1996

Showing 1-11 of 11 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • CIS countries prepare for the introduction of drug reimbursement schemes
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • CIS countries prepare for the introduction of drug reimbursement schemes
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS